868 related articles for article (PubMed ID: 15790535)
1. Rotenone induces oxidative stress and dopaminergic neuron damage in organotypic substantia nigra cultures.
Testa CM; Sherer TB; Greenamyre JT
Brain Res Mol Brain Res; 2005 Mar; 134(1):109-18. PubMed ID: 15790535
[TBL] [Abstract][Full Text] [Related]
2. L-deprenyl protects against rotenone-induced, oxidative stress-mediated dopaminergic neurodegeneration in rats.
Saravanan KS; Sindhu KM; Senthilkumar KS; Mohanakumar KP
Neurochem Int; 2006 Jul; 49(1):28-40. PubMed ID: 16490285
[TBL] [Abstract][Full Text] [Related]
3. Progressive loss of dopaminergic neurons induced by unilateral rotenone infusion into the medial forebrain bundle.
Norazit A; Meedeniya AC; Nguyen MN; Mackay-Sim A
Brain Res; 2010 Nov; 1360():119-29. PubMed ID: 20807515
[TBL] [Abstract][Full Text] [Related]
4. Dopaminergic neurotoxins require excitotoxic stimulation in organotypic cultures.
Kress GJ; Reynolds IJ
Neurobiol Dis; 2005 Dec; 20(3):639-45. PubMed ID: 15996475
[TBL] [Abstract][Full Text] [Related]
5. Acute intranigral infusion of rotenone in rats causes progressive biochemical lesions in the striatum similar to Parkinson's disease.
Saravanan KS; Sindhu KM; Mohanakumar KP
Brain Res; 2005 Jul; 1049(2):147-55. PubMed ID: 15936733
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective effect of the antiparkinsonian drug pramipexole against nigrostriatal dopaminergic degeneration in rotenone-treated mice.
Inden M; Kitamura Y; Tamaki A; Yanagida T; Shibaike T; Yamamoto A; Takata K; Yasui H; Taira T; Ariga H; Taniguchi T
Neurochem Int; 2009 Dec; 55(8):760-7. PubMed ID: 19647776
[TBL] [Abstract][Full Text] [Related]
7. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
Novikova L; Garris BL; Garris DR; Lau YS
Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
[TBL] [Abstract][Full Text] [Related]
8. Degeneration of dopaminergic neurons in the substantia nigra of zitter mutant rat and protection by chronic intake of Vitamin E.
Ueda S; Sakakibara S; Nakadate K; Noda T; Shinoda M; Joyce JN
Neurosci Lett; 2005 Jun; 380(3):252-6. PubMed ID: 15862896
[TBL] [Abstract][Full Text] [Related]
9. Selective injury to dopaminergic neurons up-regulates GDNF in substantia nigra postnatal cell cultures: role of neuron-glia crosstalk.
Saavedra A; Baltazar G; Santos P; Carvalho CM; Duarte EP
Neurobiol Dis; 2006 Sep; 23(3):533-42. PubMed ID: 16766196
[TBL] [Abstract][Full Text] [Related]
10. The acute and the long-term effects of nigral lipopolysaccharide administration on dopaminergic dysfunction and glial cell activation.
Iravani MM; Leung CC; Sadeghian M; Haddon CO; Rose S; Jenner P
Eur J Neurosci; 2005 Jul; 22(2):317-30. PubMed ID: 16045485
[TBL] [Abstract][Full Text] [Related]
11. Rotenone-induced PC12 cell toxicity is caused by oxidative stress resulting from altered dopamine metabolism.
Sai Y; Wu Q; Le W; Ye F; Li Y; Dong Z
Toxicol In Vitro; 2008 Sep; 22(6):1461-8. PubMed ID: 18579341
[TBL] [Abstract][Full Text] [Related]
12. Acute action of rotenone on nigral dopaminergic neurons--involvement of reactive oxygen species and disruption of Ca2+ homeostasis.
Freestone PS; Chung KK; Guatteo E; Mercuri NB; Nicholson LF; Lipski J
Eur J Neurosci; 2009 Nov; 30(10):1849-59. PubMed ID: 19912331
[TBL] [Abstract][Full Text] [Related]
13. PGE(2) receptor EP1 renders dopaminergic neurons selectively vulnerable to low-level oxidative stress and direct PGE(2) neurotoxicity.
Carrasco E; Casper D; Werner P
J Neurosci Res; 2007 Nov; 85(14):3109-17. PubMed ID: 17868147
[TBL] [Abstract][Full Text] [Related]
14. Dopaminergic neurons are preferentially sensitive to long-term rotenone toxicity in primary cell culture.
Radad K; Gille G; Rausch WD
Toxicol In Vitro; 2008 Feb; 22(1):68-74. PubMed ID: 17923380
[TBL] [Abstract][Full Text] [Related]
15. Inhibiting BDNF expression by antisense oligonucleotide infusion causes loss of nigral dopaminergic neurons.
Porritt MJ; Batchelor PE; Howells DW
Exp Neurol; 2005 Mar; 192(1):226-34. PubMed ID: 15698637
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II protects cultured midbrain dopaminergic neurons against rotenone-induced cell death.
Grammatopoulos TN; Ahmadi F; Jones SM; Fariss MW; Weyhenmeyer JA; Zawada WM
Brain Res; 2005 May; 1045(1-2):64-71. PubMed ID: 15910763
[TBL] [Abstract][Full Text] [Related]
17. The antioxidant drink effective microorganism-X (EM-X) pre-treatment attenuates the loss of nigrostriatal dopaminergic neurons in 6-hydroxydopamine-lesion rat model of Parkinson's disease.
Datla KP; Bennett RD; Zbarsky V; Ke B; Liang YF; Higa T; Bahorun T; Aruoma OI; Dexter DT
J Pharm Pharmacol; 2004 May; 56(5):649-54. PubMed ID: 15142343
[TBL] [Abstract][Full Text] [Related]
18. An intermittent, controlled-rate, slow progressive degeneration model of Parkinson's disease: antiparkinson effects of Sinemet and protective effects of methylphenidate.
Fleming SM; Delville Y; Schallert T
Behav Brain Res; 2005 Jan; 156(2):201-13. PubMed ID: 15582106
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial membrane depolarization and the selective death of dopaminergic neurons by rotenone: protective effect of coenzyme Q10.
Moon Y; Lee KH; Park JH; Geum D; Kim K
J Neurochem; 2005 Jun; 93(5):1199-208. PubMed ID: 15934940
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
Chaturvedi RK; Shukla S; Seth K; Chauhan S; Sinha C; Shukla Y; Agrawal AK
Neurobiol Dis; 2006 May; 22(2):421-34. PubMed ID: 16480889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
